Chilton Investment Company’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.2M Buy
498,319
+235,547
+90% +$22.6M 1.01% 24
2025
Q4
$25.2M Buy
262,772
+54,489
+26% +$5.29M 0.53% 35
2025
Q3
$19.8M Buy
208,283
+8,790
+4% +$808K 0.4% 35
2025
Q2
$17.4M Sell
199,493
-20,712
-9% -$1.76M 0.39% 34
2025
Q1
$19.8M Sell
220,205
-97,404
-31% -$8.72M 0.48% 32
2024
Q4
$25.4M Buy
317,609
+40,771
+15% +$3.53M 0.65% 32
2024
Q3
$24.9M Buy
276,838
+74,824
+37% +$6.29M 0.65% 31
2024
Q2
$15.9M Buy
202,014
+10,884
+6% +$892K 0.45% 36
2024
Q1
$16.7M Buy
191,130
+15,366
+9% +$1.31M 0.46% 37
2023
Q4
$14.5M Sell
175,764
-125,454
-42% -$9.56M 0.43% 37
2023
Q3
$23.6M Sell
301,218
-267,593
-47% -$22.4M 0.75% 29
2023
Q2
$50.1M Buy
568,811
+493,186
+652% +$42.5M 1.46% 20
2023
Q1
$6.1M Buy
75,625
+12,969
+21% +$1.06M 0.19% 49
2022
Q4
$4.87M Buy
62,656
+29,480
+89% +$2.39M 0.15% 49
2022
Q3
$2.68M Buy
33,176
+30,334
+1,067% +$2.73M 0.08% 65
2022
Q2
$255K Buy
+2,842
New +$288K 0.01% 150
2022
Q1
Sell
-20,229
Closed -$2.09M 160
2021
Q4
$2.09M Sell
20,229
-5,988
-23% -$693K 0.04% 78
2021
Q3
$3.29M Sell
26,217
-8,947
-25% -$1.16M 0.08% 68
2021
Q2
$4.37M Sell
35,164
-8,620
-20% -$1.08M 0.11% 56
2021
Q1
$5.17M Sell
43,784
-696
-2% -$81.6K 0.14% 60
2020
Q4
$5.21M Sell
44,480
-2,883
-6% -$317K 0.15% 48
2020
Q3
$4.92M Buy
47,363
+18,144
+62% +$1.82M 0.14% 54
2020
Q2
$2.68M Buy
29,219
+470
+2% +$45.1K 0.09% 70
2020
Q1
$2.59M Sell
28,749
-16,430
-36% -$1.75M 0.1% 62
2019
Q4
$5.13M Buy
45,179
+544
+1% +$59.7K 0.16% 55
2019
Q3
$4.85M Buy
44,635
+3,387
+8% +$353K 0.16% 52
2019
Q2
$4.02M Buy
41,248
+21,369
+107% +$1.95M 0.13% 56
2019
Q1
$1.81M Sell
19,879
-19,794
-50% -$1.77M 0.06% 70
2018
Q4
$3.61M Buy
39,673
+181
+0.5% +$16.9K 0.13% 59
2018
Q3
$3.88M Sell
39,492
-7,501
-16% -$693K 0.13% 63
2018
Q2
$4.02M Buy
46,993
+934
+2% +$78K 0.14% 62
2018
Q1
$3.69M Sell
46,059
-3,585
-7% -$296K 0.14% 64
2017
Q4
$4.01M Buy
49,644
+23,304
+88% +$1.87M 0.15% 62
2017
Q3
$2.05M Sell
26,340
-502
-2% -$41.7K 0.08% 78
2017
Q2
$2.38M Buy
26,842
+1,538
+6% +$130K 0.09% 77
2017
Q1
$2.04M Sell
25,304
-872
-3% -$68.1K 0.08% 79
2016
Q4
$1.86M Buy
26,176
+348
+1% +$27.3K 0.08% 71
2016
Q3
$2.23M Buy
25,828
+1,942
+8% +$169K 0.09% 64
2016
Q2
$2.07M Buy
23,886
+33
+0.1% +$2.67K 0.07% 71
2016
Q1
$1.79M Buy
23,853
+2,861
+14% +$215K 0.07% 72
2015
Q4
$1.61M Sell
20,992
-117,396
-85% -$8.84M 0.06% 82
2015
Q3
$9.26M Sell
138,388
-11,284
-8% -$831K 0.33% 46
2015
Q2
$11.1M Sell
149,672
-947,090
-86% -$72.4M 0.41% 46
2015
Q1
$85.5M Buy
1,096,762
+110,719
+11% +$8.39M 3.04% 7
2014
Q4
$71.2M Buy
986,043
+13,611
+1% +$945K 2.48% 11
2014
Q3
$60.2M Buy
+972,432
New +$61.8M 2.02% 18

Other funds holding MDT

Chilton Investment Company's MDT Position: Q1 2026 in Review

Chilton Investment Company increased its Medtronic (MDT) stake by 90% in Q1 2026, buying an estimated $22.6M and bringing the position to 498,319 shares worth $43.2M. The position accounts for 1.01% of the portfolio, ranked #24.

Chilton Investment Company first reported a position in MDT in Q3 2014 and has held it in 46 quarters since. The position peaked at $85.5M in Q1 2015. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Chilton Investment Company held 498,319 shares of Medtronic worth $43.2M as of Q1 2026.
  • Chilton Investment Company bought 235,547 Medtronic shares in Q1 2026, an estimated $22.6M.
  • Medtronic made up 1.01% of Chilton Investment Company's portfolio in Q1 2026, its #24 holding.
  • Chilton Investment Company first reported a position in Medtronic in Q3 2014 and has held it in 46 quarters since.
  • Chilton Investment Company's Medtronic position peaked at $85.5M in Q1 2015.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.